|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 991.10 INR | -2.04% |
|
+5.43% | +8.39% |
| 13/05 | Zydus Lifesciences to buy Assertio for $166.4 million | RE |
| 13/05 | Zydus to Acquire Assertio for $166.4 Million | DJ |
| Capitalization | 1LCr 1.04TCr 889.46Cr 813.82Cr 772.87Cr 1.42TCr 1.45TCr 9.74TCr 3.78TCr 47TCr 3.89TCr 3.8TCr 1,64500Cr | P/E ratio 2026 * |
21.7x | P/E ratio 2027 * | 24.1x |
|---|---|---|---|---|---|
| Enterprise value | 99TCr 1.03TCr 883.82Cr 808.66Cr 767.97Cr 1.41TCr 1.44TCr 9.68TCr 3.75TCr 47TCr 3.86TCr 3.78TCr 1,63400Cr | EV / Sales 2026 * |
3.79x | EV / Sales 2027 * | 3.33x |
| Free-Float |
24.84% | Yield 2026 * |
0.82% | Yield 2027 * | 0.76% |
Last Transcript: Zydus Lifesciences Limited
| 1 day | -2.04% | ||
| 1 week | +5.43% | ||
| Current month | +11.12% | ||
| 1 month | +4.99% | ||
| 3 months | +9.31% | ||
| 6 months | +6.03% | ||
| Current year | +8.39% |
| 1 week | 925.1 | 1,018.8 | |
| 1 month | 890.4 | 1,018.8 | |
| Current year | 835.5 | 1,018.8 | |
| 1 year | 835.5 | 1,059.05 | |
| 3 years | 484.95 | 1,324.3 | |
| 5 years | 319 | 1,324.3 | |
| 10 years | 202 | 1,324.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 46 | 27/11/2009 | |
| Director of Finance/CFO | 65 | - | |
| Director of Finance/CFO | 56 | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 06/12/2018 | |
| Chairman | 73 | 05/10/2011 | |
| Director/Board Member | 71 | 01/08/1997 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.04% | +5.43% | +9.79% | +91.04% | 1.06TCr | ||
| +1.47% | +3.13% | +9.85% | +103.62% | 4.7TCr | ||
| -0.58% | +1.32% | +68.94% | +128.10% | 3.73TCr | ||
| -0.41% | +5.88% | -4.91% | +54.36% | 1.21TCr | ||
| +3.61% | 0.00% | +35.33% | +120.35% | 908.74Cr | ||
| -3.79% | -1.73% | +60.73% | -5.92% | 750.28Cr | ||
| -1.11% | -1.19% | +18.80% | +53.70% | 739.23Cr | ||
| +0.60% | -1.12% | +61.53% | +284.31% | 684.14Cr | ||
| -3.74% | -7.55% | +152.36% | +467.63% | 602.31Cr | ||
| -1.39% | -27.43% | -11.39% | -0.17% | 577.44Cr | ||
| Average | -0.78% | -0.14% | +40.10% | +129.70% | 1.5TCr | |
| Weighted average by Cap. | -0.08% | +1.34% | +35.21% | +116.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26TCr 271.21Cr 233.03Cr 213.21Cr 202.48Cr 372.83Cr 379.18Cr 2.55TCr 989.03Cr 12TCr 1.02TCr 996.3Cr 43TCr | 28TCr 294.8Cr 253.29Cr 231.75Cr 220.09Cr 405.25Cr 412.16Cr 2.77TCr 1.08TCr 13TCr 1.11TCr 1.08TCr 47TCr |
| Net income | 4.66TCr 48Cr 42Cr 38Cr 36Cr 66Cr 68Cr 455Cr 176.34Cr 2.2TCr 181.48Cr 177.64Cr 7.68TCr | 4.15TCr 43Cr 37Cr 34Cr 32Cr 59Cr 60Cr 405.31Cr 157.08Cr 1.96TCr 161.66Cr 158.24Cr 6.84TCr |
| Net Debt | -632.45Cr -6.57Cr -5.64Cr -5.16Cr -4.9Cr -9.02Cr -9.18Cr -62Cr -24Cr -299.24Cr -25Cr -24Cr -1.04TCr | -5.15TCr -53Cr -46Cr -42Cr -40Cr -74Cr -75Cr -503.2Cr -195.02Cr -2.44TCr -200.71Cr -196.46Cr -8.5TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | 991.10 ₹ | -2.04% | 12,96,063 |
| 15/26/15 | 1,011.70 ₹ | +2.02% | 19,96,110 |
| 14/26/14 | 991.70 ₹ | +5.58% | 45,95,018 |
| 13/26/13 | 939.25 ₹ | +0.92% | 6,80,562 |
| 12/26/12 | 930.65 ₹ | -2.75% | 7,20,954 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ZYDUSLIFE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















